Loading...

APC Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Allophycocyanin, SAv-APC
Ave. Rating
Submit a Review
Product Citations
publications
APC_Streptavidin_Antibody_042123
Human peripheral blood lymphocytes were stained with APC streptavidin alone (open histogram) or Biotin anti-human CD3 (clone UCHT1) followed by (APC) Streptavidin (filled histogram).
  • APC_Streptavidin_Antibody_042123
    Human peripheral blood lymphocytes were stained with APC streptavidin alone (open histogram) or Biotin anti-human CD3 (clone UCHT1) followed by (APC) Streptavidin (filled histogram).
See APC spectral data
Cat # Size Price Quantity Check Availability Save
405207 100 µg 96€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-APC is useful for detecting biotinylated antibodies. The excitation of APC by 600-635 nm laser light induces a fluorescence emission maximum of 660 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The Streptavidin-APC solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

Each lot of this Streptavidin-APC is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the APC conjugation. For immunofluorescent staining, the recommended use of this reagent is ≤ 0.125 µg per 106 cells in 100 µl staining volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Streptavidin-APC is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-APC is 320 kD and Streptavidin alone is 52 kD.

Application References
  1. Kamimura D, et al. 2006. J. Immunol. 177:306.
  2. Andoniou CE, et al. 2005. Nature Immunology 6:1011.
  3. Chou WC,et al.2006.Blood108:3005. PubMed
  4. Malagolini N, et al. 2009. Glycobiology. 19:172. PubMed
  5. Kroeger KM, et al. 2009. J. Leukocyte Biol. PubMed
  6. Imada M, et al. 2009. Int. Immunol. 21:1151. PubMed
  7. Yi Y, et al. 2010 J. Biol Chem. 285:21233. PubMed
  8. King IL, et al. 2010. J. Immunol. 185:6138. PubMed
  9. Yokoyama T, et al. 2011. Int Immunol. PubMed
  10. Rusert P, et al. 2011. J. Exp Med. 208:1419. PubMed
  11. Bollig N, et al. 2012. PNAS. 109:8664. PubMed
  12. Nguyen V, et al. 2012. J. Immunol. 189:1081. PubMed
  13. Jager NA, et al. 2012. J Nucl Med. 53:1229. PubMed
  14. Liberman AC, et al. 2012. Mol Immunol. 50:220. PubMed
  15. Ogawa H, et al. 2012. Biochem Biophys Res Commun. 420:114. PubMed
  16. Ludin A, et al.2012. Nat Immunol. 13:1072. PubMed
  17. Sugiura D, et al. 2012. PLoS One. 7:e44770. PubMed
  18. Tani-Ichi S, et al. 2012. PNAS. 110:612. PubMed
  19. Jin L, et al. 2013. PNAS. 110:3907. PubMed
  20. Ota T, et al. 2013. J. Immunol. 191:3179. PubMed
  21. Fu X, et al. 2013. PNAS. 110:17982. PubMed
  22. Ryan SO, et al. 2014. Glycobiology. 24:362. PubMed
  23. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  24. Pilling D, et al. 2014. PLoS One. 9:93730. PubMed
  25. Matthews JA, et al. 2014. PLoS One. 9:97707. PubMed
  26. Owen KA, et al. 2014. PLoS Pathog. 10:1004159. PubMed
  27. Duek A, et al. 2014. Blood. 123:3943. PubMed
  28. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  29. Skogberg G, et al. 2014. J Immunol. 193:2187. PubMed
  30. Lundberg P, et al. 2014. J Exp Med. PubMed
  31. Martin RK, et al. 2014. PLoS One. 9:110609. PubMed
  32. Rai S, et al. 2014. PLoS One. 9:109441. PubMed
  33. Santoyo-Ramos P, et al. 2014. PLoS One. 9:112580. PubMed
  34. Jager NA, et al. 2014. J Nucl Med. 55:1945. PubMed
  35. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  36. Cabrera-Perez J, et al. 2015. J Immunol. 194:1609. PubMed
  37. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  38. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  39. Zhang L, et al. 2015. J Immunol. 194:5243. PubMed
Product Citations
  1. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  2. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  3. Preece R, et al. 2020. Gene Ther. 451:27. PubMed
  4. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  5. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  6. Cohen–Khait R, et al. 2017. Structure. 25:1867. PubMed
  7. Tarban N, et al. 2022. Cells. 11:. PubMed
  8. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  9. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
  10. Georgiadis C, et al. 2021. Leukemia. . PubMed
  11. Malagolini N, et al. 2009. Glycobiology. 0.911111111. PubMed
  12. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  13. Schneider C, et al. 2018. Cell. 174:271. PubMed
  14. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  15. Temming AR, et al. 2021. Front Immunol. 12:594773. PubMed
  16. Blake SJ, et al. 2021. Cell Rep Med. 2:100464. PubMed
  17. Sarkar R, et al. 2021. Bio Protoc. 11:e4255. PubMed
  18. Hou S, et al. 2021. Sci Immunol. 6:eabg9433. PubMed
  19. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  20. Santoyo-Ramos P, et al. 2014. PLoS One. 9:112580. PubMed
  21. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  22. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  23. Pazina T, et al. 2019. Cancer Immunol Res. 7:1633. PubMed
  24. da Mota JB, et al. 2020. J Leukoc Biol. 108:1239. PubMed
  25. Niewolik D, et al. 2022. Nucleic Acids Res. 50:2096. PubMed
  26. Io S, et al. 2021. STAR Protoc. 2:100921. PubMed
  27. Yamanaka S, et al. 2021. STAR Protocols. 2(1):100314. PubMed
  28. J L, et al. 2016. Sci Rep. 6:30904. PubMed
  29. Gaudreault V, et al. 2015. PLoS One. 10: e0140805. PubMed
  30. Jager N, et al. 2014. J Nucl Med. 55:1945. PubMed
  31. Ludin A, et al. 2012. Nat Immunol. 13:1072. PubMed
  32. Jager N, et al. 2012. J Nucl Med. 53:1222. PubMed
  33. Kimura T, et al. 2019. Am J Physiol Lung Cell Mol Physiol. 317:L271. PubMed
  34. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  35. Lebert-Ghali C, et al. 2017. Exp Hematol. 10.1016/j.exphem.2017.03.003. PubMed
  36. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  37. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  38. Jin L, et al. 2016. Stem Cell Res. 16:40-53. PubMed
  39. Palm A, et al. 2016. Sci Rep. 10.1038/srep20531. PubMed
  40. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  41. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  42. Catapano M, et al. 2020. J Invest Dermatol. 140:816. PubMed
  43. Rusert P, et al. 2011. J Exp Med. 208:1419. PubMed
  44. Liu C, et al. 2022. Cell Host Microbe. 30:53. PubMed
  45. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  46. Cao Y, et al. 2022. Nature. :. PubMed
  47. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  48. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  49. Barcala Tabarrozzi A, et al. 2016. Sci Rep. 6:36646. PubMed
  50. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  51. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  52. Duek A, et al. 2014. Blood. 123:3943. PubMed
  53. Yokoyama T, et al. 2011. J Immunol. 208:885. PubMed
  54. Cao Y, et al. 2022. Nature. 602:657. PubMed
  55. Kakizaki M, et al. 2021. Cell Death Dis. 12:1010. PubMed
  56. Calés C, et al. 2016. Mol Cell Biol. 36: 900 - 912. PubMed
  57. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  58. Bollig N, et al. 2012. Proc Natl Acad Sci U S A. 109:8664. PubMed
  59. Yi Y, et al. 2010. J Biol Chem. 285:21233. PubMed
  60. Chou W, et al. 2006. Blood. 108:3005. PubMed
  61. Tashita C, et al. 2020. World J Gastroenterol. 26:918. PubMed
  62. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  63. Wang L, et al. 2022. Nat Commun. 13:4709. PubMed
  64. Kunitomi A, et al. 2022. Cell Rep Methods. 2:100317. PubMed
  65. Tani-ichi S, et al. 2012. Proc Natl Acad Sci U S A. 110:612. PubMed
  66. Ryan S, et al. 2014. Glycobiology. 24:262. PubMed
  67. Han X, et al. 2017. Mol Ther. 25(1):274-284. PubMed
  68. Hao Y, et al. 2020. J Biol Chem. . PubMed
  69. Parikh BA, et al. 2020. Cell Rep. 32:107969. PubMed
  70. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  71. Mizoguchi I, et al. 2020. J Clin Invest. 130:6124. PubMed
  72. Locke F, et al. 2017. Mol Ther. 25(1):285-295. PubMed
  73. Jennings R, et al. 2016. Int Immunol. 28: 503 - 512. PubMed
  74. Morita N, et al. 2016. Innate Immunity. 10.1177/1753425916672312. PubMed
  75. Rai S, et al. 2014. PLoS One. 9:109441. PubMed
  76. Owen K, et al. 2014. PLoS Pathog. 10:1004159. PubMed
  77. Sugiura D, et al. 2012. PLoS One. 7:e44770. PubMed
  78. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  79. Friedrich SK, et al. 2021. Pathogens. 10: . PubMed
  80. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  81. Nguyen V, et al. 2012. J Immunol. 189: 1081. PubMed
  82. Jin L, et al. 2013. Proc Natl Acad Sci U S A. 110:3907. PubMed
  83. James KR, et al. 2020. Nat Immunol. 1.113194444. PubMed
  84. Audemard-Verger A, et al. 2017. J Immunol. 10.4049/jimmunol.1700430. PubMed
  85. Hermann BP, et al. 2018. Cell Rep. 25:1650. PubMed
  86. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  87. Pascual G, et al. 2021. Nature. 599:485. PubMed
  88. Saini SK, et al. 2021. Sci Immunol. 6:. PubMed
  89. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  90. Zhang L, et al. 2015. J Immunol. 194:5423. PubMed
  91. Skogberg G, et al. 2014. J Immunol. 193:2187. PubMed
  92. Ogawa H, et al. 2012. Biochem Biophys Res Commun. 420:114. PubMed
  93. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  94. Guichard V, et al. 2017. Elife. 6:e27215. PubMed
  95. Collins DR, et al. 2021. Immunity. 54:2372. PubMed
  96. Larcombe-Young D, et al. 2022. STAR Protoc. 3:101414. PubMed
  97. Pilling D, Gomer R 2014. PLoS One. 9:93730. PubMed
  98. Dejnirattisai W, et al. 2021. Cell. 2183:184. PubMed
  99. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  100. Jiang H, et al. 2011. PLoS One. 6:e27464. PubMed
  101. Tuekprakhon A, et al. 2022. Cell. 185:2422. PubMed
  102. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  103. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  104. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  105. Lundberg P, et al. 2014. J Exp Med. 211:2213. PubMed
  106. King I, et al. 2010. J Immunol. 185:6138. PubMed
  107. Budai Z, et al. 2021. Cells. 10:. PubMed
  108. Bainter W, et al. 2021. Sci Immunol. 6:eabf6723. PubMed
  109. Martin R, et al. 2014. PLoS One. 9:110609. PubMed
  110. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  111. Koide S, et al. 2022. iScience. 25:103603. PubMed
  112. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  113. Yewdell WT, et al. 2021. Cell Rep. 37:109961. PubMed
  114. Nguyen NT, et al. 2021. Nat Nanotechnol. 16:1424. PubMed
  115. Kosti P, et al. 2021. STAR Protocols. 2:100723. PubMed
  116. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  117. Dyson MR, et al. 2020. MAbs. 12:1829335. PubMed
  118. Mazor Y, et al. 2017. Sci Rep. 7:40098. PubMed
  119. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  120. Liberman A, et al. 2012. Mol Immunol. 50:220. PubMed
  121. GR N, et al. 2012. PLoS One. 7:e39045. PubMed
  122. Zahradník J, et al. 2021. ACS Synth Biol. Online ahead of print. PubMed
  123. Chen Y, et al. 2021. Cancer Res Treat. Online ahead of print. PubMed
  124. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  125. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  126. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  127. Hauser J, et al. 2016. Mol Immunol. 80:78-90. PubMed
  128. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  129. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  130. Nagatake T, et al. 2019. Mucosal Immunol. 12:p1082. PubMed
  131. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  132. Kroeger K, et al. 2009. J Leukoc Biol. 86:769. PubMed
  133. Fichtner ML, et al. 2022. Acta Neuropathol Commun. 10:154. PubMed
  134. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  135. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  136. Tagawa M, et al. 2016. PLoS One. 11: 0150030. PubMed
  137. Fu X, et al. 2013. Proc Natl Acad Sci U S A. 110:17892. PubMed

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 04/21/2023

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account